Nosem
Nosem
NOSEM is indicated for use in adults, adolescents and children between the ages of 2 and 11 years to treat symptoms of seasonal allergic or perennial allergic rhinitis.
In patients who have a history of moderate to severe symptoms of seasonal allergic rhinitis, prophylactic treatment with NOSEM is recommended prior to the anticipated start of the pollen season.
Each actuation contains 51,73µg mometasone furoate monohydrate (corresponding to 50 µg mometasone furoate anhydrous)
The product also contains the following inactive ingredients: Avicel RC591, benzalkonium chloride, citric acid monohydrate, glycerol, polysorbate 80, purified water and sodium citrate.
Preservative: Benzalkonium chloride 0,04 % m/m.